Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)
Condition: Alport Syndrome, X-Linked Interventions: Drug: Hydroxychloroquine Sulfate 100 milligram (mg) Tab; Drug: Benazepril hydrochloride 10 milligram (mg) Tab Sponsor: Shanghai Children's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alport Syndrome | Benazepril | Children | China Health | Hospitals | Hydroxychloroquine | Research | Study